AI Interventions in Climate Change: A Potential Solution for the NHS and Beyond

By Sumona Bose

December 23, 2023

Introduction

Artificial intelligence (AI) is reconfiguring various industries, and its potential impact on healthcare and climate change is gaining attention. The English National Health Service (NHS) aims to provide more efficient care while reducing its climate impact. However, concerns about carbon emissions from AI models have emerged. This article explores the role of AI in climate change debates and emission detection, with a focus on its implications for the NHS and beyond. It will also demonstrate how AI interventions in climate change can account for a potential solution for the NHS and beyond.

AI in Healthcare and Climate Improvement

AI tools have the potential to improve the quality and efficiency of healthcare services, including climate improvement and energy efficiency. However, the lack of standardized reporting for power, energy, and efficiency metrics in the field of AI poses challenges for direct comparison and implementation. To address this, future studies should design approaches for standard climate reporting that can be used by the NHS and AI developers.

 


Figure 1: How is the NHS using AI for clinical use cases? We take a patient, provider, process, and public health approach to reviewing the implementation of AI tools. Deployed tools are either being routinely used in clinical practice or are in clinical pilots. Near tools are in a research environment and being applied to clinical problems. Future tools are yet to be applied to clinical settings and require validation.

 

UK’s Net Zero Strategy

As the host of the United Nations Climate Change Conference (COP26) in 2021, the UK has an opportunity to showcase the progress of the NHS towards achieving net zero emissions by 2040. AI is expected to play a major role in future healthcare delivery, including managing the efficiency of health system operations. For example, AI can optimize building management and reduce energy consumption.

Exploring AI’s Climate Impact

While the literature on AI models, computational power, and processing times is extensive, there is a lack of focus on the climate impact of AI in clinical settings. Further exploration is needed to understand the efficiency of AI models and how they can be used to reduce carbon emissions in healthcare.

Considering the Social Care Sector

The social care sector, which is developing new technologies such as fall detection algorithms, has the advantage of considering sustainability and carbon impact from inception to implementation. Lessons from this sector can be applied to healthcare to reduce climate impact.

The Need for Further Research and Action

To better understand the climate impact of AI development and weigh the cost-benefit of implementing AI technologies, more research is needed. The NHS should support the development of AI tools by implementing standardized climate reporting and exploring opportunities for reducing model size and improving efficiency. The impact of AI tools themselves should be established, reduced, and offset as part of overall reduction and offsetting targets.

As AI technologies continue to advance in healthcare, it is crucial to consider their climate impact and address it throughout their life cycle.

Reference url

Recent Posts

access to medicines
         

Quantifying EU Medicine Access Challenges

🔍 Are we creating a healthcare system that truly works for everyone?

Recent findings from EFPIA shed light on alarming inequities in access to medicines across Europe, showing that only 46% of approved drugs are available to patients this year. With significant delays affecting smaller markets and critical cancer treatments, this article explores the systemic barriers at play and innovative solutions proposed to ensure fair access.

Dive into the full article to uncover how we can collectively shape a more equitable healthcare landscape.

#SyenzaNews #healthcare #MarketAccess

UK Medicine Payment Rates
      

Revitalizing Innovation: The Impact of UK Medicine Payment Rates

💡 Are the UK’s medicine payment rates stifling innovation in life sciences?

Recent analysis reveals that the staggering 23.5% payment rate for pharmaceuticals is not just limiting NHS spending but also curtailing R&D investments, delaying new drug launches, and threatening workforce stability. If we can lower these rates to below 10%, we could unleash significant growth and restore the UK’s competitive edge in the global life sciences landscape.

Discover the critical insights and recommendations that could reshape the future of healthcare in the UK.

#SyenzaNews #healthcarepolicy #innovation

Blinatumomab benefit assessment
            

Blinatumomab Benefit Assessment for ALL and Health Economics

🚀 How does a groundbreaking therapy change the landscape of acute lymphoblastic leukemia treatment?

The recent benefit assessment of Blinatumomab by the German Federal Joint Committee reveals critical insights into its potential as a consolidation therapy for adults with Philadelphia chromosome-negative B-cell precursor ALL. With its orphan drug status promising automatic benefits, the article explores the implications of its high cost and economic impacts, shedding light on the balance needed between innovation and sustainability in healthcare.

Jump into the full analysis to understand how this could impact clinical practice and health economics.

#SyenzaNews #HealthEconomics #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.